These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27997342)

  • 21. A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets.
    Baz M; Paskel M; Matsuoka Y; Zengel JR; Cheng X; Treanor JJ; Jin H; Subbarao K
    J Virol; 2015 Jul; 89(13):6907-17. PubMed ID: 25903333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
    Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible reduced effectiveness of the 2009 H1N1 component of live, attenuated influenza vaccine.
    Myers CA; Faix DJ; Blair PJ
    Clin Infect Dis; 2011 Jul; 53(2):207-8. PubMed ID: 21690631
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.
    Bracco Neto H; Farhat CK; Tregnaghi MW; Madhi SA; Razmpour A; Palladino G; Small MG; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2009 May; 28(5):365-71. PubMed ID: 19395948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
    Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses.
    Pena L; Vincent AL; Ye J; Ciacci-Zanella JR; Angel M; Lorusso A; Gauger PC; Janke BH; Loving CL; Perez DR
    J Virol; 2011 Jan; 85(1):456-69. PubMed ID: 20962084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localized mucosal response to intranasal live attenuated influenza vaccine in adults.
    Barría MI; Garrido JL; Stein C; Scher E; Ge Y; Engel SM; Kraus TA; Banach D; Moran TM
    J Infect Dis; 2013 Jan; 207(1):115-24. PubMed ID: 23087433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Live attenuated intranasal influenza vaccine.
    Esposito S; Montinaro V; Groppali E; Tenconi R; Semino M; Principi N
    Hum Vaccin Immunother; 2012 Jan; 8(1):76-80. PubMed ID: 22251995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season.
    King JP; McLean HQ; Meece JK; Levine MZ; Spencer SM; Flannery B; Belongia EA
    Vaccine; 2018 Feb; 36(9):1214-1219. PubMed ID: 29395525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cold-adapted X-31 live attenuated 2009 pandemic H1N1 influenza vaccine elicits protective immune responses in mice and ferrets.
    Jang YH; Byun YH; Lee DH; Lee KH; Lee YJ; Lee YH; Park JK; Song CS; Seong BL
    Vaccine; 2013 Feb; 31(9):1320-7. PubMed ID: 23313655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Approaches for The Development of Live Attenuated Influenza Vaccines.
    Blanco-Lobo P; Nogales A; Rodríguez L; Martínez-Sobrido L
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30813325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity.
    Belshe RB; Coelingh K; Ambrose CS; Woo JC; Wu X
    Vaccine; 2010 Feb; 28(9):2149-56. PubMed ID: 20003926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Live attenuated seasonal and pandemic influenza vaccine in school-age children: a randomized controlled trial.
    Klick B; Durrani S; Chan KH; Ip DK; Chou ES; Kwok HK; Ng S; Chiu SS; Peiris JS; Leung GM; Cowling BJ
    Vaccine; 2013 Apr; 31(15):1937-43. PubMed ID: 23434387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age at Vaccination and Timing of Infection Do Not Alter Vaccine-Associated Enhanced Respiratory Disease in Influenza A Virus-Infected Pigs.
    Souza CK; Rajão DS; Loving CL; Gauger PC; Pérez DR; Vincent AL
    Clin Vaccine Immunol; 2016 Jun; 23(6):470-482. PubMed ID: 27030585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.
    Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM
    J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains.
    Yeolekar LR; Ganguly M; Tyagi P; Ingle NB; Stittelaar KJ; Waal L; Scorza FB; Mahmood K; Dhere RM
    Vaccine; 2018 Nov; 36(46):6944-6952. PubMed ID: 30322745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children.
    King JC; Fast PE; Zangwill KM; Weinberg GA; Wolff M; Yan L; Newman F; Belshe RB; Kovacs A; Deville JG; Jelonek M;
    Pediatr Infect Dis J; 2001 Dec; 20(12):1124-31. PubMed ID: 11740317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.
    Rhorer J; Ambrose CS; Dickinson S; Hamilton H; Oleka NA; Malinoski FJ; Wittes J
    Vaccine; 2009 Feb; 27(7):1101-10. PubMed ID: 19095024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.
    King JC; Treanor J; Fast PE; Wolff M; Yan L; Iacuzio D; Readmond B; O'Brien D; Mallon K; Highsmith WE; Lambert JS; Belshe RB
    J Infect Dis; 2000 Feb; 181(2):725-8. PubMed ID: 10669363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immediate and broad-spectrum protection against heterologous and heterotypic lethal challenge in mice by live influenza vaccine.
    Seo SU; Lee KH; Byun YH; Kweon MN; Seong BL
    Vaccine; 2007 Nov; 25(47):8067-76. PubMed ID: 17919786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.